# Royalty Pharma plc (RPRX)

Royalty Pharma (RPRX) stock hits a 52-week high, driven by strong Q3 performance, strategic buybacks, and positive analyst sentiment. Recent dealmaking, including the Evrysdi royalty acquisition, further bolsters bullish trends.

### About Royalty Pharma plc
Royalty Pharma plc is a biopharmaceutical royalty company that invests in and acquires royalty interests in innovative medicines.  
Royalty Pharma plc uses the ticker $RPRX for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Royalty Pharma plc (RPRX) trading volume is up 36.91% from the previous week.
- Royalty Pharma plc (RPRX) social dominance is up 10.67% from the previous week.
- Royalty Pharma plc (RPRX) Galaxy Score™ is up 81.48% from the previous month.
- Royalty Pharma plc (RPRX) creators is up 46.24% from the previous month.
- Royalty Pharma plc (RPRX) engagements is up 627.94% from the previous week.
- Royalty Pharma plc (RPRX) mentions is up 54.49% from the previous month.
- Royalty Pharma plc (RPRX) posts created is up 66.67% from the previous week.
- Royalty Pharma plc Price hit a 52-Week high of $45.70 for the hour

### Price: $45.20
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$rprx/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$rprx/time-series/close.tsv)  
The stock price is near a 52-week high, supported by positive market sentiment, recent dealmaking like the Evrysdi royalty acquisition, strong Q3 performance, and strategic buybacks, with social sentiment reinforcing this bullish trend. An analyst upgrade to 'Buy' from UBS further bolsters this positive price action.  

24-Hour: 0.85%
7-Day: 1.12%
30-Day: 14.26%

1-Year High: $45.20 on 2026-02-13  
1-Year Low: $30.90 on 2025-04-08  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$rprx/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$rprx/time-series/alt_rank.tsv)  
Royalty Pharma plc (RPRX) is currently AltRank #1,684 based on combined combined social and market metrics
Daily Average: [-----]  
[--] Week: [-----] +824  
[--] Month: [-----] +64  
[--] Months: [-----] +154  
[--] Year: [-----] +1,039  
1-Year High: [-----] on 2026-01-29  
1-Year Low: [---] on 2025-07-04  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$rprx/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$rprx/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] +17  
[--] Month: [--] +22  
[--] Months: [--] [---]  
[--] Year: [--] [---]  
1-Year High: [--] on 2025-03-17  
1-Year Low: [--] on 2025-10-10  
  
  
### Engagements: [-----] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$rprx/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$rprx/time-series/interactions.tsv)  
Current Value: [-----]  
Daily Average: [-----]  
[--] Week: [------] +628%  
[--] Month: [-------] +65%  
[--] Months: [-------] +3.50%  
[--] Year: [---------] -38%  
1-Year High: [------] on 2025-08-25  
1-Year Low: [---] on 2026-01-03  

Engagements by network (24h):
TikTok: [--]
Reddit: [--]
YouTube: [--]
X: [-----]
News: [--]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$rprx/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$rprx/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [--]  
[--] Week: [---] +16%  
[--] Month: [---] +54%  
[--] Months: [-----] -11%  
[--] Year: [-----] +14%  
1-Year High: [---] on 2025-06-28  
1-Year Low: [--] on 2026-01-01  

Mentions by network (24h):
TikTok: [--]
Reddit: [--]
YouTube: [--]
X: [--]
News: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$rprx/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$rprx/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Royalty Pharma plc (RPRX) in the last [--] hours which is down 21% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [---] +20%  
[--] Month: [---] +46%  
[--] Months: [---] -46%  
[--] Year: [-----] +36%  
1-Year High: [---] on 2025-06-28  
1-Year Low: [--] on 2026-01-01  

The most influential creators that mention Royalty Pharma plc in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@ParadiseTraderr](/creator/twitter/ParadiseTraderr) | [--]    | [---]       | [--]     | [---]         |
| [@MarcJacksonLA](/creator/twitter/MarcJacksonLA)     | [--]    | [-----]     | [--]     | [---]         |
| [@SDegrijse](/creator/twitter/SDegrijse)             | [--]    | [---]       | [--]     | [---]         |
| [@TradersCom](/creator/twitter/TradersCom)           | [--]    | [------]    | [--]     | [--]          |
| [@X_Twit_ter_X](/creator/twitter/X_Twit_ter_X)       | [--]    | [-----]     | [--]     | [--]          |
| [@EarningsSeason_](/creator/twitter/EarningsSeason_) | [--]    | [---]       | [--]     | [--]          |
| [@MultibaggAIEU](/creator/twitter/MultibaggAIEU)     | [--]    | [---]       | [--]     | [--]           |

[View More](/list/creators/$rprx/100)
  
  
### Sentiment: 88%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$rprx/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$rprx/time-series/sentiment.tsv)  
Current Value: 88%  
Daily Average: 72%  
[--] Week: 50% -17%  
[--] Month: 82% +10%  
[--] Months: 82% +4%  
[--] Year: 82% -2%  
1-Year High: 100% on 2025-03-16  
1-Year Low: 15% on 2025-12-18  

Most Supportive Themes:
- Royalty Pharma's Financial Performance and Strategy: (30%) Discussions highlight Royalty Pharma's financial guidance, including expected shareholder returns and cash flow, alongside its strategic approach to acquiring biopharmaceutical royalties.
- Biopharmaceutical Investments and Partnerships: (25%) Posts frequently mention Royalty Pharma's involvement in funding and acquiring stakes in biopharmaceutical companies and their drug royalties, indicating strategic partnerships and investment potential.
- Stock Performance and Valuations: (20%) Analysis of Royalty Pharma's stock performance, including price targets, and comparisons to other healthcare stocks, suggests a focus on its investment value.
  
Most Critical Themes:
- Valuation Comparisons and Market Sentiment: (15%) Some posts compare Royalty Pharma's valuation multiples to other sectors, suggesting potential overvaluation or a need for further justification of its current market position.
- Insider Trading and Ownership Changes: (10%) Mentions of insider trading activity, including CEO stock purchases and past ownership by notable investors, prompt scrutiny and analysis of the company's internal confidence and strategic direction.
  
  
  
### Social Dominance: 0.00362%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$rprx/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$rprx/time-series/social_dominance.tsv)  
Current Value: 0.00362%  
Daily Average: 0.00947%  
[--] Week: 0.00332% +0.00031999999999999997%  
[--] Month: 0.0052% -0.0023%  
[--] Months: 0.0052% -0.0004000000000000002%  
[--] Year: 0.0052% -0.019%  
1-Year High: 0.042% on 2025-06-29  
1-Year Low: 0.002% on 2025-09-30  
  
  
### Market Dominance: 0.022%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$rprx/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$rprx/time-series/market_dominance.tsv)  
Current Value: 0.022%  
Daily Average: 0%  
1-Year High: 0.506% on 2025-03-31  
1-Year Low: 0.018% on 2025-10-28  
  
  
### Market Cap: $19,360,237,076
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$rprx/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$rprx/time-series/market_cap.tsv)  
Current Value: $19,360,237,076  
Daily Average: $15,518,548,245  
[--] Week: $19,360,237,076 +1.50%  
[--] Month: $19,360,237,076 +14%  
[--] Months: $19,360,237,076 +25%  
[--] Year: $19,360,237,076 +38%  
1-Year High: $19,360,237,076 on 2026-02-13  
1-Year Low: $13,371,776,306 on 2025-04-08  

### Top Royalty Pharma plc Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"Notable [--] Week Highs Cont. from Part [--] $NEE $NEOG $NGG $NHI $NI $NIC $NMR $NTST $NVS $NWN $OGS $PCG $PFE $PHM $PINE $PNW $OGS $PFE $PHM $PINE $PNW $POR $PR $PRA $PUMP $RIG $RLAY $RPRX $SBRA $SEI $SFL $SIF $SKM $SLF $SN $SND $SOBO $SPXC $SR $SUZ $SWX $SYRE $TAK Part [--] Cont. -"  
[X Link](https://x.com/MarcJacksonLA/status/2022363300521218132) [@MarcJacksonLA](/creator/x/MarcJacksonLA) 2026-02-13T17:32Z [----] followers, [---] engagements


"UPDATED GROWTH PORTFOLIO WATCHLIST [--]. $LMND [--]. $OKLO [--]. $HOOD [--]. $PI [--]. $KTOS [--]. $RR [--]. $DPRO [--]. $JOBY [--]. $ACHR [--]. $AVAV $HOOK $MAMO $ARHS $ITCI $GLXG $AKYA $IVDA $BBCP $PRZO $OCS $OPFI $LFVN $LIXT $RPRX $SONM $USGO $SWVL $SPCB $ISPO $ETON $MASS $SVV $CING $SERV $WOK $ZCAR $PROP: Insider Buying + Scaling Production ⚡ Prairie Operating continues expanding in the U.S. oil and gas sector backed by over $5M in insider purchases and growing operational momentum in the DJ Basin. Recent Highlights: Expanded to [-----] net acres in the DJ Basin https://t.co/6O83WWMO64 $PROP: Insider Buying + Scaling"  
[X Link](https://x.com/ParadiseTraderr/status/2022342847681417461) [@ParadiseTraderr](/creator/x/ParadiseTraderr) 2026-02-13T16:11Z [---] followers, [---] engagements


"I didn't get to share Part [--] of my $ANAB piece earlier because the Stack was down but it seems they have it fixed so here you go. Impressive red to green day today and still so undervalued in light of recent royalty stream updates and the valuation of their peers in Celiac. Also covered $RPRX deal with Teva to develop an anti-IL-15 in Celiac and the huge opportunity in the space in general which really will be the "third IBD" once we see stronger proof-of-concept datasets in the clinic which I feel is coming soon"  
[X Link](https://x.com/MattBiotech/status/2021667447301173513) [@MattBiotech](/creator/x/MattBiotech) 2026-02-11T19:27Z [----] followers, [----] engagements


"#earnings before the open on Wednesday February [--] [----] $SHOP $VRT $U $MCD $HUM $KHC $TMUS $TSEM $BWA $GFS $THC $NTES $HLT $R $MLM $FNMA $RDCM $SITE $OTLY $GNRC $PSN $RPRX $VERX $VPG $WAB $SN $SOLS $SPMC $SW $TEX $BXMT $CHEF $CLBT $CRTO $AVTR $GLIBA $NI $NNN $KRNT $LAD $PYPD $HCSG $PAG $TMHC $UE $ULCC $VERU https://www.earningswhispers.com/calendar The most anticipated earnings releases for the week of February [--] [----] are @RobinhoodApp $HOOD @AppLovin $APP @coinbase $COIN @AsteraLabs $ALAB @nebiusai #NBIS @Shopify $SHOP @Vertiv $VRT @Pinterest $PINS @AristaNetworks $ANET and @unity $U."  
[X Link](https://x.com/eWhispers/status/2021284548055618016) [@eWhispers](/creator/x/eWhispers) 2026-02-10T18:06Z 551.6K followers, 74.7K engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing